LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Search

Guardant Health Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

85.01 1.12

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

84.73

Max

88.01

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-36M

-128M

Pardavimai

16M

281M

Pelnas, tenkantis vienai akcijai

-0.5

Pelno marža

-45.684

Darbuotojai

2,490

EBITDA

-37M

-119M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+57.8% upside

Dividendai

By Dow Jones

Kitas uždarbis

2026-04-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-1.7B

12B

Ankstesnė atidarymo kaina

83.89

Ankstesnė uždarymo kaina

85.01

Naujienos nuotaikos

By Acuity

50%

50%

154 / 351 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Very Strong Bearish Evidence

Guardant Health Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-13 19:08; UTC

Svarbiausios naujienos

TotalEnergies Shutting Production in Qatar, Iraq Amid Fighting in Middle East

2026-03-13 18:48; UTC

Uždarbis
Pagrindinės rinkos jėgos

Capricor Therapeutics Falls on Wider-Than-Expected 4Q Loss

2026-03-13 17:10; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Central Bank Decisions in Focus After Jump in Energy Prices

2026-03-13 17:10; UTC

Svarbiausios naujienos

Week Ahead for FX, Bonds: Central Bank Decisions -2-

2026-03-13 16:47; UTC

Svarbiausios naujienos

The Week in Oil: Hormuz Crisis Pushes Brent Above $100

2026-03-13 22:27; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Bahrain Faces Uncertainty But Has Support Amid War, S&P Says -- Market Talk

2026-03-13 22:13; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Saudi Arabia Seen as Able to Weather Iran Conflict, S&P Says -- Market Talk

2026-03-13 22:04; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Emirate of RAK Outlook Stable Despite Iran War, S&P Says -- Market Talk

2026-03-13 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Trump Administration Set to Receive $10 Billion Fee for Brokering TikTok Deal -- WSJ

2026-03-13 20:50; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-13 20:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Financial Services Roundup: Market Talk

2026-03-13 20:02; UTC

Rinkos pokalbiai

Canada Rate Hike in 2026 Would Mark 'Extraordinarily Bad' Policy -- Market Talk

2026-03-13 19:50; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Posts Weekly Gains As Middle East Conflict Drags On -- Market Talk

2026-03-13 19:35; UTC

Svarbiausios naujienos

Oil Prices Hover Near $100. India Asks Iran to Allow 23 Tankers Through Strait of Hormuz. -- Barrons.com

2026-03-13 19:00; UTC

Rinkos pokalbiai

U.S. Natural Gas Futures Settle Lower -- Market Talk

2026-03-13 18:49; UTC

Svarbiausios naujienos

The Iran War Could Upend AI. Here's How. -- Barrons.com

2026-03-13 18:24; UTC

Svarbiausios naujienos

Impact of Middle East Conflict on TotalEnergies Activities

2026-03-13 18:00; UTC

Svarbiausios naujienos

Is War Good For the Economy? -- WSJ

2026-03-13 17:23; UTC

Rinkos pokalbiai

U.S. Oil Rig Count Rises by 1 to 412 -- Market Talk

2026-03-13 16:46; UTC

Rinkos pokalbiai
Svarbiausios naujienos

European Indexes End Week Lower as Oil Takes Driving Seat -- Market Talk

2026-03-13 16:38; UTC

Svarbiausios naujienos

Higher Oil Prices Could Bring a Global Economic Shock. This Is the Number to Watch. -- Barrons.com

2026-03-13 16:34; UTC

Įsigijimai, susijungimai, perėmimai

EQT Says It Received Around CHF21 Bln in Total From Galderma Share Sales

2026-03-13 16:33; UTC

Įsigijimai, susijungimai, perėmimai

EQT Receives Proceeds of Around CHF1.3B From Sell-Down

2026-03-13 16:32; UTC

Įsigijimai, susijungimai, perėmimai

EQT Completes Exit From Galderma

2026-03-13 16:20; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Financial Services Roundup: Market Talk

2026-03-13 16:20; UTC

Rinkos pokalbiai

Health Care Roundup: Market Talk

2026-03-13 16:15; UTC

Svarbiausios naujienos

Why Exxon and Energy Stocks Finally Started to Rise This Week as the Iran War Escalated -- Barrons.com

2026-03-13 16:11; UTC

Rinkos pokalbiai

Carney Tries to Put Dismal Canada Jobs Data in Context -- Market Talk

2026-03-13 16:00; UTC

Svarbiausios naujienos

Here's Where the U.S. Economy Is Most Vulnerable to Iran War -- WSJ

2026-03-13 15:48; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Oil Futures Turn Higher as Supply Worries Remain -- Market Talk

Akcijų palyginimas

Kainos pokytis

Guardant Health Inc Prognozė

Kainos tikslas

By TipRanks

57.8% į viršų

12 mėnesių prognozė

Vidutinis 132.58 USD  57.8%

Aukščiausias 175 USD

Žemiausias 110 USD

Remiantis 21 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Guardant Health Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

21 ratings

20

Pirkti

1

Laikyti

0

Parduoti

Techninis įvertinimas

By Trading Central

38.86 / 47.41Palaikymas ir pasipriešinimas

Trumpalaikis periodas

Very Strong Bearish Evidence

Vidutinės trukmės periodas

Bearish Evidence

Ilgalaikis periodas

Bullish Evidence

Rinkos nuotaikos

By Acuity

154 / 351 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Vidutinis

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Guardant Health Inc

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, data sets, and analytics in the United States and internationally. The company provides Guardant360; Guardant360 LDT; Guardant360 CDx Test; Guardant360 Response Test; Guardant360 TissueNext Test; GuardantINFINITY Test; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI Test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It offers Shield Test; Guardant Reveal Test for adjuvant treatment selection in early-stage cancer patients; Smart Liquid Biopsy Platform; and Guardant Galaxy, an AI-backed digital pathology platform that helps improve cancer biomarker detection. In addition, the company offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kits fulfillment. The company has a collaboration agreement with Illumina, Inc. for the sharing of specimen samples to advance cancer research; and with ConcertAI to form first data-as-a-service that integrates clinical and tumor profiling data to accelerate cancer therapy research and development. The company was incorporated in 2011 and is headquartered in Palo Alto, California.
help-icon Live chat